Daiichi Sankyo (OTCMKTS:DSNKY) Shares Gap Up - What's Next?

Key Points

• Daiichi Sankyo's stock price experienced a significant gap up, opening at $27.21 from a previous close of $25.74.
• Nomura Securities upgraded Daiichi Sankyo to a "strong-buy" rating, contributing to an overall average rating of "Strong Buy" for the stock.
• The company has a market cap of $51.13 billion and reported a price-to-earnings ratio of 26.20.

Daiichi Sankyo Co., Ltd. - Sponsored ADR (OTCMKTS:DSNKY - Get Free Report)'s share price gapped up prior to trading on Tuesday . The stock had previously closed at $25.74, but opened at $27.21. Daiichi Sankyo shares last traded at $27.01, with a volume of 58,643 shares changing hands.

Analysts Set New Price Targets

Separately, Nomura Securities upgraded shares of Daiichi Sankyo to a "strong-buy" rating in a report on Friday, June 6th. One research analyst has rated the stock with a Strong Buy rating, According to data from MarketBeat, Daiichi Sankyo has an average rating of "Strong Buy".

Daiichi Sankyo Trading Up 0.7%

The company has a quick ratio of 1.85, a current ratio of 2.53 and a debt-to-equity ratio of 0.06. The business's fifty day moving average is $23.86 and its 200-day moving average is $24.13. The stock has a market capitalization of $48.27 billion and a PE ratio of 24.74.

Daiichi Sankyo Company Profile

Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.